A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) Formulations
Completed
Eli Lilly and Company
Phase 3
2008-06-01
Testosterone replacement treatment is the most effective way of treating hypogonadism in men.
Acrux has a propriety testosterone replacement product- Testosterone MD-Lotion (cutaneous
solution), and this study will evaluate the efficacy via pharmacokinetics of various doses of
this product. The study will also assess safety of the product.
A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulations
Completed
Eli Lilly and Company
Phase 3
2008-10-01
Testosterone replacement treatment is the most effective way of treating hypogonadism in men.
Acrux has a propriety testosterone replacement product, Testosterone MD-Lotion and this study
will assess the occurrence of skin safety events for a further two months of continuous use
of the Testosterone MD-Lotion® (cutaneous solution) after completion of the MTE08
(NCT00702650) trial.
A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations
Completed
Eli Lilly and Company
Phase 2
2007-10-01
Testosterone replacement treatment is the most effective way of treating hypogonadism in men.
Acrux has a propriety testosterone replacement product, Testosterone MD-Lotion and this study
will evaluate pharmacokinetics of testosterone MD-Lotion formulations.The study will also
assess safety of the product.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
